{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Catching Up on New Medications: New FDA Approvals

Description

This article has been approved by the Orthopaedic Nurses Certification Board for Category B credit toward recertification as an ONC.

Purpose of Activity

To provide information on a sample of new brand name drugs and first-time generics approved in 2015.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the indications for several newly approved drugs.
  2. Recognize the potential side effects of a sample of new brand name drugs.
  3. Discuss the administration methods and pharmacokinetics of several new drugs.
Price: $15.00

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Test Code: ON0116D
Published: Jan/Feb 2016
Expires: 3/6/2020
Passing Score: 12/16 (75%)
Authors: Beatrice B. Turkoski, RN, PhD
Categories: Drug Therapy , Orthopaedics